Global Influenza Vaccine Market: By Type (Inactivated influenza vaccine (IIV) (Quadrivalent and Trivalent) and Live-attenuated influenza vaccine (LAIV)); Process (Egg Based, Cell Culture-Based, and Recombinant); Route of Administration (Injectable and Intra-nasal); Age Group (Pediatric and Adult); Distribution Channel (Hospitals & Pharmacies, Government Suppliers, and Others); Region— Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2024–2032
Global influenza vaccine market was valued at US$ 8.78 billion in 2023 and is projected to hit the market valuation of US$ 22.71 billion by 2032 at a CAGR of 11.07% during the forecast period 2024–2032. Read More
We Are Trusted By These Great Companies!
Published On: 11-Jan-2024 | Format: | Report ID: AA0124744